Respiratory Infections News

Influenza viruses and coronaviruses have both caused major pandemics. We asked Infectious Disease News Editorial Board Members Gitanjali Pai, MD, AAHIVS, FIDSA, an infectious disease physician at Memorial Hospital and Physicians Clinic in Stilwell, Oklahoma, and chief medical officer for the Oklahoma State Department of Health, and Raghavendra Tirupathi, MD, FACP, medical director for Keystone Infectious Diseases/HIV, chair of infection prevention at Summit Health and clinical assistant professor of medicine at Penn State University School of Medicine, which group of viruses they would eliminate, if possible, and why.

HIV captured me during my first clinical rotation in medical school, early in the Plague Years, around the same time that AIDS was getting its name from CDC.

Following days of deliberations, vaccine advisory committees for the FDA and CDC each voted unanimously in favor of allowing eligible Americans to choose their own COVID-19 vaccine booster shots.

Axcella Therapeutics announced that it is recruiting for a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of AXA1125 in patients with exertional fatigue related to long COVID.

Just 8 weeks after it authorized booster doses of the Pfizer-BioNTech COVID-19 vaccine for people at high risk for severe disease, the FDA on Thursday announced that any adult is now eligible for an extra shot.

Researchers have begun a long-term study of the impacts of COVID-19 on children, the NIH announced.

Pfizer said Tuesday that it is seeking emergency use authorization from the FDA for its investigational COVID-19 pill and will allow generic drug makers to produce the novel antiviral for low- and middle-income countries.

Patients with COVID-19 who enrolled in an automated text messaging system with twice daily check-ins were 68% less likely to die than those who did not use it, according to an ACP press release.

A joint consensus review from the Infectious Diseases Society of America and the American Society for Microbiology outlined the potential role and challenges of SARS-CoV-2 sequencing in clinical care.

On Sept. 9, President Joe Biden announced a six-pronged plan to combat a rise in COVID-19 cases that included federal vaccine mandates for roughly 100 million U.S. workers.